ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Cash from Investing Activities of $450000.0 for Q1 2026, up 2704.17% YoY from $16047.5 in Q1 2025, and up 115.0% sequentially from -$3.0 million in Q4 2025.
ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Cash from Investing Activities across 10 years of filings, most recently posting $450000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 2704.17% year-over-year to $450000.0; the TTM figure through Mar 2026 stood at -$2.6 million (down 40505.1% YoY), while the FY2025 annual figure was -$3.0 million, down 23479.87% from the prior year.
- Cash from Investing Activities grew to $450000.0 in Q1 2026, from -$3.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for NDRA reached as high as $450000.0 in Q1 2026 and fell as low as -$3.0 million in Q4 2025.
- The 5-year median for Cash from Investing Activities is -$23796.0 (2024), against an average of -$255215.8.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 98.56% — and 2026, when it soared 2704.17%.
- A 5-year view of Cash from Investing Activities shows it stood at -$38563.0 in 2022, then jumped by 105.91% to $2279.0 in 2023, then soared by 382.67% to $11000.0 in 2024, then plunged by 27372.73% to -$3.0 million in 2025, then soared by 115.0% to $450000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $450000.0, -$3.0 million, and -$17280.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | 450,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 450,000.00 |
| Mar 31, 2026 | 450,000.00 |
| Dec 31, 2025 | -3.00 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -17,280.00 |
| Mar 31, 2025 | -17,280.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | -23,796.00 |
| Mar 31, 2024 | -23,796.00 |
| Dec 31, 2023 | 2,279.00 |
| Dec 31, 2023 | 2,279.00 |
| Mar 31, 2023 | -27,000.00 |
| Mar 31, 2023 | -27,000.00 |
| Dec 31, 2022 | -38,563.00 |
| Dec 31, 2022 | -38,563.00 |
| Sep 30, 2022 | -14,861.00 |
| Sep 30, 2022 | -14,861.00 |
| Jun 30, 2022 | -59,800.00 |
| Jun 30, 2022 | -59,800.00 |